FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2166548265> ?p ?o ?g. }

• W2166548265 endingPage "11" @default.
• W2166548265 startingPage "906" @default.
• W2166548265 abstract "Cyclooxygenase inhibitors show promise in chemoprevention and therapy of certain carcinomas, an effect that may be additive to that of standard chemotherapy. The purpose of this study was to evaluate the efficacy of combined therapy using the cyclooxygenase inhibitor, piroxicam, and mitoxantrone against a relevant canine model of human invasive bladder cancer.Fifty-five dogs with transitional cell carcinoma of the urinary bladder were enrolled in this nonrandomized one-armed prospective multi-institutional clinical trial. Mitoxantrone was administered i.v. (5 mg/m(2)) every 21 days for four treatments, and piroxicam was administered p.o. (0.3 mg/kg/day) for the study duration. Tumor staging was performed at baseline, day 42 and every 3 months after protocol completion. Endpoints included time-to-treatment failure and survival time (ST).Response data were available for 48 dogs and included one complete response, 16 partial responses, 22 with disease stabilization, and 9 with progressive disease for an overall 35.4% measurable response rate. Subjective improvement occurred in 75% of treated dogs. Median time-to-treatment failure and ST were 194 and 350 days, respectively. Using censoring and end point definitions similar to those of previous reports of dogs treated with piroxicam alone, the median ST in this study was 291 days, compared with 181 days with piroxicam alone. Diarrhea and azotemia were the most common treatment complications.Mitoxantrone/piroxicam induced remission more frequently than previously reported for either drug as a single agent in this canine model of invasive human transitional cell carcinoma. Additional evaluation of these drugs in combination protocols should be explored." @default.
• W2166548265 created "2016-06-24" @default.
• W2166548265 creator A5004898872 @default.
• W2166548265 creator A5008407518 @default.
• W2166548265 creator A5020704256 @default.
• W2166548265 creator A5025780981 @default.
• W2166548265 creator A5027923577 @default.
• W2166548265 creator A5029351012 @default.
• W2166548265 creator A5032716520 @default.
• W2166548265 creator A5033929186 @default.
• W2166548265 creator A5036871307 @default.
• W2166548265 creator A5052118711 @default.
• W2166548265 creator A5071104159 @default.
• W2166548265 creator A5071871368 @default.
• W2166548265 creator A5072089519 @default.
• W2166548265 date "2003-02-01" @default.
• W2166548265 modified "2023-09-27" @default.
• W2166548265 title "Clinical evaluation of mitoxantrone and piroxicam in a canine model of human invasive urinary bladder carcinoma." @default.
• W2166548265 cites W148101548 @default.
• W2166548265 cites W1503583732 @default.
• W2166548265 cites W1590255381 @default.
• W2166548265 cites W1597512265 @default.
• W2166548265 cites W1786169419 @default.
• W2166548265 cites W189060137 @default.
• W2166548265 cites W1899590409 @default.
• W2166548265 cites W1936664258 @default.
• W2166548265 cites W1957837469 @default.
• W2166548265 cites W1966825260 @default.
• W2166548265 cites W1986616957 @default.
• W2166548265 cites W1988528060 @default.
• W2166548265 cites W1995949483 @default.
• W2166548265 cites W2006091738 @default.
• W2166548265 cites W2012053260 @default.
• W2166548265 cites W2022740328 @default.
• W2166548265 cites W2023940753 @default.
• W2166548265 cites W2046293893 @default.
• W2166548265 cites W2051466603 @default.
• W2166548265 cites W2059972525 @default.
• W2166548265 cites W2072709583 @default.
• W2166548265 cites W2084562362 @default.
• W2166548265 cites W2085014380 @default.
• W2166548265 cites W2088905899 @default.
• W2166548265 cites W2124414749 @default.
• W2166548265 cites W2147753291 @default.
• W2166548265 cites W2270699631 @default.
• W2166548265 cites W2330709704 @default.
• W2166548265 cites W2338139126 @default.
• W2166548265 cites W2427774130 @default.
• W2166548265 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12576466" @default.
• W2166548265 hasPublicationYear "2003" @default.
• W2166548265 type Work @default.
• W2166548265 sameAs 2166548265 @default.
• W2166548265 citedByCount "30" @default.
• W2166548265 countsByYear W21665482652012 @default.
• W2166548265 countsByYear W21665482652014 @default.
• W2166548265 countsByYear W21665482652015 @default.
• W2166548265 countsByYear W21665482652016 @default.
• W2166548265 countsByYear W21665482652017 @default.
• W2166548265 countsByYear W21665482652018 @default.
• W2166548265 countsByYear W21665482652019 @default.
• W2166548265 countsByYear W21665482652020 @default.
• W2166548265 countsByYear W21665482652021 @default.
• W2166548265 countsByYear W21665482652022 @default.
• W2166548265 countsByYear W21665482652023 @default.
• W2166548265 crossrefType "journal-article" @default.
• W2166548265 hasAuthorship W2166548265A5004898872 @default.
• W2166548265 hasAuthorship W2166548265A5008407518 @default.
• W2166548265 hasAuthorship W2166548265A5020704256 @default.
• W2166548265 hasAuthorship W2166548265A5025780981 @default.
• W2166548265 hasAuthorship W2166548265A5027923577 @default.
• W2166548265 hasAuthorship W2166548265A5029351012 @default.
• W2166548265 hasAuthorship W2166548265A5032716520 @default.
• W2166548265 hasAuthorship W2166548265A5033929186 @default.
• W2166548265 hasAuthorship W2166548265A5036871307 @default.
• W2166548265 hasAuthorship W2166548265A5052118711 @default.
• W2166548265 hasAuthorship W2166548265A5071104159 @default.
• W2166548265 hasAuthorship W2166548265A5071871368 @default.
• W2166548265 hasAuthorship W2166548265A5072089519 @default.
• W2166548265 hasConcept C121608353 @default.
• W2166548265 hasConcept C126322002 @default.
• W2166548265 hasConcept C126894567 @default.
• W2166548265 hasConcept C141071460 @default.
• W2166548265 hasConcept C142724271 @default.
• W2166548265 hasConcept C159641895 @default.
• W2166548265 hasConcept C204787440 @default.
• W2166548265 hasConcept C2775919214 @default.
• W2166548265 hasConcept C2776694085 @default.
• W2166548265 hasConcept C2778065480 @default.
• W2166548265 hasConcept C2778139025 @default.
• W2166548265 hasConcept C2778822529 @default.
• W2166548265 hasConcept C2779762690 @default.
• W2166548265 hasConcept C2780352672 @default.
• W2166548265 hasConcept C2780923524 @default.
• W2166548265 hasConcept C71924100 @default.
• W2166548265 hasConcept C90924648 @default.
• W2166548265 hasConceptScore W2166548265C121608353 @default.
• W2166548265 hasConceptScore W2166548265C126322002 @default.
• W2166548265 hasConceptScore W2166548265C126894567 @default.

• next